VIA Pharmaceuticals, Inc.
VIAP
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Net Income | 54.23% | 45.71% | 3.30% | -4.97% | -3.47% |
| Total Depreciation and Amortization | -45.09% | -46.03% | -38.73% | -33.66% | -33.79% |
| Total Amortization of Deferred Charges | -77.56% | -72.55% | 427.71% | 6,984.40% | -- |
| Total Other Non-Cash Items | -29.60% | -2.43% | 8.65% | 12.99% | -3.28% |
| Change in Net Operating Assets | 26.43% | 51.52% | 575.51% | 128.79% | 644.55% |
| Cash from Operations | 48.52% | 43.25% | 44.74% | 36.15% | 37.22% |
| Capital Expenditure | -- | 100.00% | 78.29% | 90.31% | 88.48% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 78.02% | 90.67% | 88.83% |
| Total Debt Issued | -60.00% | -70.00% | -2.50% | 362.50% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -35.00% | -63.89% | -69.77% | -92.50% | -13.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -60.00% | -70.01% | -2.55% | 361.87% | 5,000,900.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.32% | -48.21% | 71.27% | 88.00% | 90.15% |